These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7185922)

  • 41. Biodefence lab criticized.
    Dolgin E
    Nature; 2009 Jul; 460(7255):556-7. PubMed ID: 19641559
    [No Abstract]   [Full Text] [Related]  

  • 42. Hot zones.
    Fox CH
    Science; 1999 Apr; 284(5412):262-3. PubMed ID: 10232973
    [No Abstract]   [Full Text] [Related]  

  • 43. [Biosafety in laboratories concerning exposure to biological agents].
    Vonesch N; Tomao P; Di Renzi S; Vita S; Signorini S
    G Ital Med Lav Ergon; 2006; 28(4):444-56. PubMed ID: 17380946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Aug; 35(34):540-2, 547-9. PubMed ID: 3018469
    [No Abstract]   [Full Text] [Related]  

  • 45. Laboratory-acquired SARS raises worries on biosafety.
    Orellana C
    Lancet Infect Dis; 2004 Feb; 4(2):64. PubMed ID: 14959754
    [No Abstract]   [Full Text] [Related]  

  • 46. Fears grow over lab-bred flu.
    Butler D
    Nature; 2011 Dec; 480(7378):421-2. PubMed ID: 22193075
    [No Abstract]   [Full Text] [Related]  

  • 47. Leads from the MMWR. Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement.
    JAMA; 1986 Oct; 256(14):1857, 1861, 1868 passim. PubMed ID: 3020262
    [No Abstract]   [Full Text] [Related]  

  • 48. High-security labs: Life in the danger zone.
    Marx V
    Nature; 2014 Jan; 505(7483):437-41. PubMed ID: 24429638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mycobacteria. General culture methodology and safety considerations.
    Allen BW
    Methods Mol Biol; 1998; 101():15-30. PubMed ID: 9921466
    [No Abstract]   [Full Text] [Related]  

  • 50. Safety in microbiology: a review.
    Collins CH
    Biotechnol Genet Eng Rev; 1984; 1():141-65. PubMed ID: 6400191
    [No Abstract]   [Full Text] [Related]  

  • 51. Laboratory safety.
    Grist NR
    Lancet; 1979 Dec; 2(8154):1244. PubMed ID: 92653
    [No Abstract]   [Full Text] [Related]  

  • 52. AIDS virus creates lab risk.
    Barnes DM
    Science; 1988 Jan; 239(4838):348-9. PubMed ID: 3336787
    [No Abstract]   [Full Text] [Related]  

  • 53. [Risk assessment on laboratory biosafety of Leishmania].
    Xiong YH; Guan YY; Cao JP
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Jun; 24(3):342-4, 363. PubMed ID: 23012965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protecting researchers from instrument biohazards.
    Hambleton P; Dedonato G
    Biotechniques; 1992 Sep; 13(3):450-3. PubMed ID: 1389178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microbiological hazards in laboratories can be controlled.
    Burton DJ
    Occup Health Saf; 1986 May; 55(5):37-8. PubMed ID: 3086785
    [No Abstract]   [Full Text] [Related]  

  • 56. Containment considerations for the biotechnology industry.
    Liberman DF; Fink R
    Occup Med; 1991; 6(2):271-83. PubMed ID: 2047977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A microbiological survey of automated biochemical machines.
    Newsom SW; Matthews J
    J Clin Pathol; 1980 Jun; 33(6):566-70. PubMed ID: 7400361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Health technology assessment: Choice between a cytotoxic safety cabinet and an isolator for oncology drug reconstitution in Tunisia.
    Boufaied M; Bouhlel M; Soussi MA; Lazreg O; Khrouf MR
    J Oncol Pharm Pract; 2021 Jul; 27(5):1132-1138. PubMed ID: 32838684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Protective strategy against human immunodeficiency virus and other retroviral infection on laboratory work].
    Kitamura K; Yamazaki S
    Nihon Rinsho; 1993 Sep; 51 Suppl():517-21. PubMed ID: 8271429
    [No Abstract]   [Full Text] [Related]  

  • 60. Containment system for the preparation of vitrified-hydrated virus specimens.
    Jeng TW; Talmon Y; Chiu W
    J Electron Microsc Tech; 1988 Apr; 8(4):343-8. PubMed ID: 3199217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.